Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
Add more filters










Publication year range
1.
Oncogene ; 29(2): 201-13, 2010 Jan 14.
Article in English | MEDLINE | ID: mdl-19838210

ABSTRACT

Approximately 80% of breast cancers express the estrogen receptor-alpha (ERalpha) and are treated with anti-estrogens. Resistance to these agents is a major cause of mortality. We have shown that estrogen inhibits Notch, whereas anti-estrogens or estrogen withdrawal activate Notch signaling. Combined inhibition of Notch and estrogen signaling has synergistic effects in ERalpha-positive breast cancer models. However, the mechanisms whereby Notch-1 promotes the growth of ERalpha-positive breast cancer cells are unknown. Here, we demonstrate that Notch-1 increases the transcription of ERalpha-responsive genes in the presence or absence of estrogen via a novel chromatin crosstalk mechanism. Our data support a model in which Notch-1 can activate the transcription of ERalpha-target genes via IKKalpha-dependent cooperative chromatin recruitment of Notch-CSL-MAML1 transcriptional complexes (NTC) and ERalpha, which promotes the recruitment of p300. CSL binding elements frequently occur in close proximity to estrogen-responsive elements (EREs) in the human and mouse genomes. Our observations suggest that a hitherto unknown Notch-1/ERalpha chromatin crosstalk mediates Notch signaling effects in ERalpha-positive breast cancer cells and contributes to regulate the transcriptional functions of ERalpha itself.


Subject(s)
Breast Neoplasms/genetics , Estrogen Receptor alpha/physiology , I-kappa B Kinase/genetics , Receptor, Notch1/physiology , Animals , Blotting, Western , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , E1A-Associated p300 Protein/genetics , E1A-Associated p300 Protein/metabolism , Estrogen Antagonists/pharmacology , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , I-kappa B Kinase/metabolism , Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics , Immunoglobulin J Recombination Signal Sequence-Binding Protein/metabolism , Mammary Neoplasms, Experimental/drug therapy , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Oligopeptides/pharmacology , Promoter Regions, Genetic/genetics , Receptor, Notch1/genetics , Receptor, Notch1/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tamoxifen/pharmacology , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic , Xenograft Model Antitumor Assays
2.
Clin Exp Immunol ; 134(1): 57-62, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12974755

ABSTRACT

Hyperbaric oxygen (HBO) is 100% oxygen administered at elevated atmospheric pressure to patients with inflammatory diseases. We developed an in vitro model to investigate the effects of HBO on stimulus-induced proinflammatory cytokine transcription and translation. Human blood-derived monocyte-macrophages were stimulated before being transferred to an HBO chamber where they were incubated at 97.9% O2, 2.1% CO2, 2.4 atmospheres absolute, 37 degrees C. Controls were maintained in the same warm room at normoxia at sea level, hyperoxia or increased pressure alone. A 90-min HBO exposure inhibited IL-1beta synthesized in response to lipopolysaccharide by 23%, lipid A by 45%, phytohaemagglutinin A (PHA) by 68%, and tumour necrosis factor (TNF)-alpha by 27%. HBO suppressed lipopolysaccharide-, lipid A- and PHA-induced TNF-alpha by 29%, 31% and 62%, respectively. HBO transiently reduced PHA-induced steady state IL-1beta mRNA levels. Hyperoxia alone and pressure alone did not affect cytokine production. The immunosuppressive effect of HBO was no longer evident in monocyte-macrophages exposed to HBO for more than 3 h. Interestingly, cells exposed to HBO for 12 h synthesized more IL-1beta than cells cultured under control conditions. In summary, HBO exposure transiently suppresses stimulus-induced proinflammatory cytokine production and steady state RNA levels.


Subject(s)
Cytokines/immunology , Hyperbaric Oxygenation , Macrophages/immunology , Cells, Cultured , Humans , Immunosuppression Therapy , Interleukin-1/biosynthesis , Interleukin-1/genetics , Lipid A/pharmacology , Lipopolysaccharides/pharmacology , Phytohemagglutinins/pharmacology , RNA, Messenger/analysis , Stimulation, Chemical , Time Factors , Tumor Necrosis Factor-alpha/biosynthesis
3.
Apoptosis ; 7(6): 499-510, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12370492

ABSTRACT

Hyperbaric oxygen (HBO) is 100% oxygen administered at elevated atmospheric pressure. In this study, we examined the effect of HBO on hematopoietic cell apoptosis. Cells exposed to HBO were incubated in a chamber containing 97.9% O(2) and 2.1% CO(2) at 2.4 atmospheres absolute (ATA). HBO enhanced spontaneous HL-60 cell apoptosis in a time-dependent manner; a 12 h exposure increased apoptosis by 42%. Exposing these cells to hyperoxia at standard atmospheric pressure (95% O(2), 5% CO(2) at 1 ATA) or increased pressure alone (8.75% O(2), 2.1% CO(2) at 2.4 ATA) had minimal effect on apoptosis. HBO also enhanced stimulus-induced apoptosis. HL-60 cells stimulated to die using gamma radiation underwent 33% more apoptosis than cells exposed to radiation alone. HBO enhanced melphalan, camptothecin, and chlorambucil-induced apoptosis by 22%, 13%, and 8%, respectively. Jurkat cells stimulated to die with anti-Fas antibody underwent 44% more apoptosis when exposed to HBO. Spontaneous apoptosis was increased by 15% in HBO-exposed murine thymocytes. HBO's effect on apoptosis did not require new protein synthesis. As expected, HBO exposure increased the intracellular concentration of H(2)O(2). Incubating HL-60 cells in the presence of dehydroascorbic acid partially abrogated HBO-induced increases in intracellular H(2)O(2) and apoptosis. In summary, HBO enhances spontaneous and stimulus-induced apoptosis in hematopoietic cells, at least in part, by enhancing the intracellular accumulation of H(2)O(2).


Subject(s)
Apoptosis/drug effects , Hematopoietic System/cytology , Hematopoietic System/drug effects , Hyperbaric Oxygenation , Animals , Apoptosis/physiology , Caspase 3 , Caspases/biosynthesis , Catalase/metabolism , Dehydroascorbic Acid/pharmacology , Female , HL-60 Cells , Humans , Hydrogen Peroxide/metabolism , Hydrostatic Pressure , Hyperoxia , In Vitro Techniques , Jurkat Cells , Mice , Mice, Inbred BALB C , Nucleic Acid Synthesis Inhibitors/pharmacology , Oxygen/physiology , Protein Synthesis Inhibitors/pharmacology , Reactive Oxygen Species/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/drug effects
5.
Immunology ; 103(1): 26-34, 2001 May.
Article in English | MEDLINE | ID: mdl-11380689

ABSTRACT

This study examined a number of tissues during early gestation in foetal sheep to determine the earliest site of Vlambda expression and time of generation of the Vlambda repertoire. Tissues, including spleen, liver, gut, blood and bone marrow, were obtained from 48, 55, 60 and 63 gestational day (g.d.) ovine foetuses and cDNA libraries were prepared from them by reverse transcription-polymerase chain reaction. Clones were randomly selected from cDNA libraries and subjected to sequencing. Analysis of these sequences and comparison with a pool of germline genes led to the following conclusions. The expression of Vlambda occurs earlier in spleen (48 g.d.) than in all of the other tissues examined. Also, diversity is seen earlier and at higher levels in early foetal spleen than in all of the other tissues examined. In this regard, it is notable that splenic Vlambda expression is readily apparent even before such gut-associated lymphoid tissue as the ileal Peyer's patch (IPP) has developed. Two germline Vlambda genes, 5.1 and 5.3 predominate in early immunoglobulin lambda light-chain gene rearrangement. Examination of Jlambda usage revealed the existence of a new Jlambda gene and its utilization during the early phases of the development of the ovine antibody repertoire. This study indicates that sites other than the IPP contribute to the diversification of the Vlambda repertoire in sheep. We suggest that it is likely that foetal spleen may provide a partially diversified B-cell repertoire before the IPP becomes active as a major site for massive clonal expansion and extensive diversification of B cells.


Subject(s)
Fetus/immunology , Immunoglobulin Variable Region/genetics , Immunoglobulin lambda-Chains/genetics , Sheep/embryology , Animals , Antibody Diversity , Base Sequence , DNA, Complementary/genetics , Embryonic and Fetal Development/immunology , Gene Rearrangement, B-Lymphocyte, Light Chain , Immunoglobulin J-Chains/genetics , Molecular Sequence Data , Sheep/genetics , Sheep/immunology , Spleen/embryology , Spleen/immunology
6.
Curr Opin Immunol ; 12(3): 301-6, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10781405

ABSTRACT

Transcriptional control of T cell development is a complex and rapidly moving area of investigation. Recent advances reveal critical roles for several transcription factors in T cell commitment, differentiation and selection. In particular, new roles for E proteins as well as members of the Notch signaling pathway have been described. Additionally, a unique function of Ikaros in chromatin remodeling reveals a novel mechanism by which transcriptional control may be exerted.


Subject(s)
T-Lymphocytes/immunology , Thymus Gland/cytology , Transcription, Genetic , Cell Death , Cell Differentiation , Gene Expression Regulation , Models, Immunological , Thymus Gland/growth & development , Transcription Factors/metabolism
7.
Results Probl Cell Differ ; 23: 209-28, 1999.
Article in English | MEDLINE | ID: mdl-9950035

ABSTRACT

The ubiquitin-proteasome pathway is responsible for the regular turnover of a wide variety of proteins and is a critical regulator of many cellular processes. Although this pathway is abundant and ubiquitous, it is also discriminating. This specificity is achieved because there are multiple levels of regulation at work in the pathway. X-ray crystallographic data on the eukaryotic 20S proteasome suggest that substantial rearrangement of the alpha rings, probably mediated by the association of additional regulatory complexes, is required to allow access of substrates into the inner core of the complex. The associated complexes also confer a ubiquitin-dependence on the proteasome, requiring that potential substrates be tagged with chains of ubiquitin proteins. The presence of multiple ubiquitinating enzymes that favor distinct substrates provides a way for a cell to regulate what proteins are to be ubiquitinated. In some cases ubiquitination is not required, but we now know that other modifications, such as phosphorylation and protein-protein interactions, are also important for targeting proteins for degradation. Even with the existence of so many regulatory controls, it is difficult to imagine how one complex can perform so many tasks. As more information is gathered about the proteasome, we begin to understand that all proteasomes are not exactly the same. For example, there is strong evidence that proteasomes involved in antigen presentation differ in both composition and function from proteasomes involved in other processes. The past image of the proteasome as a static structure is being shed, and a new image is emerging that portrays the complex as dynamic and flexible, able to tailor its composition and function to meet a particular need. With this new image of the proteasome in mind, investigators are looking at the potential involvement of the proteasome in cell death. Inhibitor studies have demonstrated a requirement for proteasomes during apoptosis in noncycling and differentiated cells. Similar studies in cycling cells suggest that the proteasome may regulate a cell's decision to proliferate, differentiate, or die. It will be necessary in the future to supplement the peptide and lactacystin studies with work that is not inhibitor-driven since the specificity of an inhibitor for a particular protease is always in question. In addition, a real understanding of how proteasomes may regulate this process awaits the identification of its substrates. With cell death investigators showing increased interest in proteasomes, it may be possible in the next few years to determine the precise role of the proteasome in the pathways that lead to the death of a cell.


Subject(s)
Apoptosis/physiology , Cysteine Endopeptidases/physiology , Eukaryotic Cells/cytology , Eukaryotic Cells/enzymology , Multienzyme Complexes/physiology , Proteasome Endopeptidase Complex
8.
J Immunol ; 162(2): 635-8, 1999 Jan 15.
Article in English | MEDLINE | ID: mdl-9916679

ABSTRACT

The Notch receptor protein was originally identified in Drosophila and is known to mediate cell to cell communication and influence cell fate decisions. Members of this family have been isolated from invertebrates as well as vertebrates. We isolated mouse Notch-1 in a yeast two-hybrid screen with Nur77, which is a protein that has been shown previously to be required for apoptosis in T cell lines. The data presented below indicate that Notch-1 expression provides significant protection to T cell lines from TCR-mediated apoptosis. These data demonstrate a new antiapoptotic role for Notch-1, providing evidence that, in addition to regulating cell fate decisions, Notch-1 can play a critical role in controlling levels of cell death in T cells.


Subject(s)
Apoptosis/immunology , Membrane Proteins/physiology , Receptors, Antigen, T-Cell/physiology , Receptors, Cell Surface , Animals , Cell Death/genetics , Cell Death/immunology , Cell Line , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Humans , Hybrid Cells , Lymphoma, T-Cell , Mice , Nuclear Receptor Subfamily 4, Group A, Member 1 , Receptor, Notch1 , Receptors, Cytoplasmic and Nuclear , Receptors, Steroid , Retroviridae/genetics , Saccharomyces cerevisiae/genetics , T-Lymphocytes/metabolism , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcription Factors/physiology , Tumor Cells, Cultured
9.
Proc Natl Acad Sci U S A ; 96(2): 622-7, 1999 Jan 19.
Article in English | MEDLINE | ID: mdl-9892683

ABSTRACT

A major question in end-stage T cell development is how T cell receptor(TCR) ligation on immature CD4(+)CD8(+) double positive thymocytes is translated into either survival (positive selection) or apoptotic (negative selection) signals. Because different types of antigen-presenting cells (APCs) induce positive or negative selection in the thymus and express different costimulatory molecules, involvement of such costimulatory molecules in determining cell fate of DP thymocytes is considered here. If TCR-generated signals are modulated by APCs, this should be reflected in the activation of distinct biochemical pathways. We here demonstrate that costimulatory signals involved in negative selection also are required for induction of protein expression of Nur77 and its family members. These transcription factors are critically involved in negative but not positive selection. In contrast, the signals that costimulate negative selection are not required for induction of several molecular events associated with positive selection. These include activation of the immediate early gene Egr-1, the mitogen-activated protein kinase ERK2, and surface expression of the CD69 marker. Thus, costimulation for negative selection selectively provides signals for activation of apoptotic mediators. These data provide molecular insights into how TCR-engagement by ligands on different thymic APCs can determine cell fate.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , DNA-Binding Proteins/genetics , Gene Expression Regulation/immunology , Immediate-Early Proteins , Signal Transduction/genetics , Thymus Gland/immunology , Transcription Factors/genetics , Animals , Antigen-Presenting Cells/immunology , Antigens, CD/immunology , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Cells, Cultured , Early Growth Response Protein 1 , Flow Cytometry , Mice , Mice, Knockout , Mitogen-Activated Protein Kinase 1 , Nuclear Receptor Subfamily 4, Group A, Member 1 , Receptors, Antigen, T-Cell/immunology , Receptors, Cytoplasmic and Nuclear , Receptors, Steroid
10.
J Immunol ; 161(10): 5438-44, 1998 Nov 15.
Article in English | MEDLINE | ID: mdl-9820519

ABSTRACT

Ig repertoire diversification in cattle was studied in the ileal Peyer's patch (IPP) follicles of young calves and in the spleens of late first-trimester bovine fetuses. To investigate follicular diversification, individual IPP follicles were isolated by microdissection; VA diversity was examined by RT-PCR and subsequent cloning and sequencing. When 52 intrafollicular sequences from a 4-wk-old calf were determined and compared, two major groups, one of 23 members and the other of 25, could be delineated. An examination of these groups revealed clear genealogic relationships that implicated in situ diversification of V lambda sequences within the confines of an IPP follicle. V lambda expression was also examined in early (95 and 110 gestational day) fetal bovine spleens. Although earlier studies in cattle and sheep implicated the IPP as a likely site of Ab diversification, a close investigation of V lambda sequences in late first-trimester fetal calves revealed that diversity appears in the early fetal spleen before the establishment of a diverse repertoire in the ileum. When the sequences for the fetal spleen were compared with an existing pool of germline sequences, we found evidence of possible gene conversion events and possible untemplated point mutations occurring in sequences recovered from fetal spleens. We conclude that IPP is not the sole site of VA diversification in cattle. Also, as suggested for rabbits, cattle may use both gene conversion and untemplated somatic point mutation to diversify their primary VA repertoire.


Subject(s)
Antibody Diversity/genetics , Genes, Immunoglobulin , Immunoglobulin Variable Region/genetics , Immunoglobulin lambda-Chains/genetics , Animals , Animals, Newborn/genetics , Animals, Newborn/growth & development , Animals, Newborn/immunology , Base Sequence , Cattle , Cloning, Molecular , Fetus , Gene Rearrangement, B-Lymphocyte, Light Chain , Ileum , Immunoglobulin Variable Region/isolation & purification , Immunoglobulin lambda-Chains/isolation & purification , Molecular Sequence Data , Organ Specificity/genetics , Organ Specificity/immunology , Peyer's Patches/chemistry , Peyer's Patches/growth & development , Peyer's Patches/immunology , Point Mutation/immunology , Spleen/chemistry , Spleen/growth & development , Spleen/immunology
11.
Int Rev Immunol ; 15(3-4): 165-83, 1997.
Article in English | MEDLINE | ID: mdl-9222818

ABSTRACT

Research in several species has revealed that different types of mammals have evolved divergent molecular and cellular strategies for generating immunoglobulin diversity. Other chapters in this text have highlighted the specific characteristics unique to chicken, rabbit, mouse, human and sheep B lymphocyte development; namely indicating differences in the mechanisms of diversity and the site of primary B cell development. Studies of the bovine system have indicated that like the sheep system, the ileal Peyer's patch (IPP) is a likely chicken bursal equivalent, and is a site of primary B lymphocyte development. Substantial investigation in sheep has indicated that Ig diversity is created by untemplated somatic mutation and intense selective pressure (Reynaud et al., 1991). The frequency of alteration in the sheep Ig light chain gene locus also is characteristic of the bovine system, however, recent evidence from sequencing of bovine lambda light chain genes indicates that one mechanism that contributes to diversity is gene conversion, utilizing several pseudogenes located in the Ig locus (Parng et al., 1996). The mechanism by which this hyperalteration of Ig genes occurs in both sheep and cattle is poorly understood and is thus the focus of considerable investigation. The study of events in the IPP may also have informative ramifications for secondary diversification of the Ig repertoire by somatic hyperalteration in germinal centers.


Subject(s)
Antibody Diversity , Cattle/immunology , Gene Rearrangement, B-Lymphocyte , Genes, Immunoglobulin , Amino Acid Sequence , Animals , Base Sequence , Cattle/genetics , DNA, Complementary/genetics , Gene Conversion , Germinal Center/immunology , Immune System/embryology , Immune System/growth & development , Lymphoid Tissue/embryology , Lymphoid Tissue/growth & development , Lymphoid Tissue/immunology , Molecular Sequence Data , Peyer's Patches/embryology , Peyer's Patches/growth & development , Peyer's Patches/immunology , Pseudogenes , Sheep/genetics , Sheep/immunology , Species Specificity
12.
Crit Rev Eukaryot Gene Expr ; 7(1-2): 179-93, 1997.
Article in English | MEDLINE | ID: mdl-9034721

ABSTRACT

Apoptosis, one of the best-studied forms of programmed cell death processes, plays an important role during the development and life-cycle of most multicellular organisms. The mechanisms underlying the initiation and manifestation of apoptotic cell death are the focus of the most recent cell death research. Generally, it is believed that cells are eliminated via a highly ordered and controlled program. This program might consist of the successive activation of unique apoptosis-specific genes, which are solely involved in the regulation of the programmed cell death. However, more and more evidence is accumulating that novel genes are not activated or induced during apoptosis, but rather many well-known genes previously described for their roles in processes such as proliferation and differentiation and belonging, for example, to the protein families of immediate-early genes and transcription factors become activated. The death-specific feature is achieved thereby by the extent, combination, and specific timing of gene expression. The involvement of the three different transcription factors glucocorticoid receptor (GR), nur77, and activator protein 1 (AP-1) in such a scenario is the focus of this review.


Subject(s)
Apoptosis/genetics , Gene Expression Regulation , Transcription Factors/metabolism , Animals , DNA-Binding Proteins/metabolism , Female , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 1 , Receptors, Cytoplasmic and Nuclear , Receptors, Glucocorticoid/metabolism , Receptors, Steroid , Signal Transduction/physiology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Transcription Factor AP-1/metabolism
13.
Cell Death Differ ; 4(8): 647-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-16465276
14.
J Immunol ; 157(12): 5478-86, 1996 Dec 15.
Article in English | MEDLINE | ID: mdl-8955197

ABSTRACT

In humans and mice, extensive gene rearrangement is the major mechanism of diversification of the primary Ig repertoire. This study shows that cattle depart from this pattern because rearrangement in the light chain locus is sharply limited. Furthermore, in cattle, gene conversion contributes to the diversification of the primary light chain repertoire. Sequencing of germ-line and expressed Vlambda genes revealed three important features. First, the germ line contained a number of Vlambda pseudogenes. In fact, 14 (70%) of the 20 germ-line genes identified and sequenced were pseudogenes, because they had one or more of the following defects: lack of recombination signal sequences at the 3' end, stop codons within the reading frame or truncations, and/or insertions or deletions that resulted in loss of reading frame. Second, Vlambda cDNA from ileal Peyer's patch B cells demonstrated that the light chain repertoire arises from only a small number of V(J) rearrangements. Even though two J genes were identified in the germ line, all of the expressed Vlambda genes examined contained the same J segment, indicating that only a single J gene participates in rearrangement at the lambda locus. Third, a significant number of departures from the germ-line sequences of rearranged Vlambda can be traced to donor sequences of one or more Vlambda pseudogenes. We conclude that a limited number of rearrangements and gene conversion play a role in contributing to the diversification of the primary lambda repertoire. Furthermore, while clear indications of a role for somatic mutation in lambda diversification was seen, V gene rearrangement was not a major factor.


Subject(s)
Antibody Diversity , Cattle/genetics , Gene Conversion , Genes, Immunoglobulin , Immunoglobulin lambda-Chains/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle/immunology , Gene Rearrangement, B-Lymphocyte, Light Chain , Male , Molecular Sequence Data , Sequence Alignment , Sequence Homology, Nucleic Acid
16.
EMBO J ; 15(15): 3835-44, 1996 Aug 01.
Article in English | MEDLINE | ID: mdl-8670888

ABSTRACT

Cell death in many different organisms requires the activation of proteolytic cascades involving cytosolic proteases. Here we describe a novel requirement in thymocyte cell death for the 20S proteasome, a highly conserved multicatalytic protease found in all eukaryotes. Specific inhibitors of proteasome function blocked cell death induced by ionizing radiation, glucocorticoids or phorbol ester. In addition to inhibiting apoptosis, these signals prevented the cleavage of poly(ADP-ribose) polymerase that accompanies many cell deaths. Since overall rates of protein degradation were not altered significantly during cell death in thymocytes, these results suggest that the proteasome may either degrade regulatory protein(s) that normally inhibit the apoptotic pathway or may proteolytically activate protein(s) than promote cell death.


Subject(s)
Apoptosis , Cysteine Endopeptidases/physiology , Multienzyme Complexes/physiology , T-Lymphocytes/cytology , Acetylcysteine/analogs & derivatives , Acetylcysteine/pharmacology , Animals , Apoptosis/drug effects , Blotting, Western , Cysteine Proteinase Inhibitors/pharmacology , DNA Ligases/antagonists & inhibitors , Dexamethasone/pharmacology , Leupeptins/pharmacology , Mice , Mice, Inbred BALB C , Proteasome Endopeptidase Complex , Proteins/metabolism
17.
Eur J Immunol ; 26(5): 1170-4, 1996 May.
Article in English | MEDLINE | ID: mdl-8647183

ABSTRACT

Signals generated by T cell receptor (TCR) cross-linking (or phorbol 12-myristate-13-acetate + Ca2+ ionophore), glucocorticoids or ionizing radiation all stimulate apoptotic cell death in thymocytes by signals that are initially distinct from each other. However, when these stimuli were administered to thymocyte cultures that were maintained under an atmosphere containing less than 20 ppm oxygen as opposed to one that contained 18.5% molecular oxygen, cell death was inhibited or abrogated, suggesting that the induction of death by all three different stimuli depend on the presence of molecular oxygen. Studies of the effects of the cysteine analog N-acetyl cysteine (NAC) with normal thymocytes demonstrated that this antioxidant inhibited the induction of death by each of the different stimuli in a manner the paralleled anaerobiosis. Furthermore, studies with thymocytes demonstrated that the induction of nur77, a gene shown to be involved in thymocyte apoptosis signaled through the TCR or its surrogates, is not inhibited by NAC or dependent upon molecular oxygen. The possible implications for negative selection of NAC-mediated inhibition of TCR-signaled thymocyte cell death was examined in thymic organ culture. Treatment of these cultures with NAC provided significant protection against staphylococcal enterotoxin B-mediated deletion of V beta 8-expressing thymocytes.


Subject(s)
Apoptosis/drug effects , Oxygen/physiology , T-Lymphocytes/drug effects , Thymus Gland/drug effects , Acetylcysteine/pharmacology , Anaerobiosis/drug effects , Animals , Apoptosis/radiation effects , Calcimycin/pharmacology , Cell Death/drug effects , DNA-Binding Proteins/genetics , Enterotoxins/pharmacology , Female , Gene Expression Regulation/drug effects , Male , Mercaptoethanol/pharmacology , Mice , Mice, Inbred BALB C , Nuclear Receptor Subfamily 4, Group A, Member 1 , Organ Culture Techniques , Oxygen/pharmacology , Receptors, Antigen, T-Cell, alpha-beta , Receptors, Cytoplasmic and Nuclear , Receptors, Steroid , Staphylococcus aureus , T-Lymphocytes/physiology , Tetradecanoylphorbol Acetate/pharmacology , Transcription Factors/genetics
18.
Curr Opin Immunol ; 8(2): 245-54, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8725948

ABSTRACT

The regulation of cell proliferation and the selection against autoreactive cells in the lymphoid system both occur through the induction of apoptosis. Many of the signals that induce apoptosis in lymphocytes are now well defined. Interactions between Fas and its ligand have emerged as a major mechanism for the deletion of activated peripheral T cells and autoreactive B cells. Although the signal-transduction pathway leading from engagement of Fas to apoptosis is not entirely clear, significant advances have been made recently. There has also been progress in the elucidation of the mechanisms that regulate apoptosis in the immune system.


Subject(s)
Apoptosis/immunology , Homeostasis/immunology , Immune System/physiology , Animals
20.
J Cell Biochem ; 60(1): 18-22, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8825411

ABSTRACT

Elimination of self-reactive T lymphocytes occurs during T-cell development in the thymus by a process known as negative selection. The mechanism that drives negative selection is apoptosis. To identify genes that regulate apoptosis in the mouse thymus, a library of negatively selected T cells was constructed and, by subtractive screening, several differentially regulated genes were isolated. Two transcripts that are repressed during cell death were identified, in addition to two induced transcripts. Further experiments demonstrated that cell death in thymocytes can occur via several induction pathways and each pathway appears to be regulated by a unique cascade of genes.


Subject(s)
Apoptosis/genetics , Genes, Regulator , Thymus Gland/ultrastructure , Animals , Apoptosis/radiation effects , DNA, Complementary , Genomic Library , Mice , T-Lymphocytes/radiation effects , T-Lymphocytes/ultrastructure , Thymus Gland/radiation effects
SELECTION OF CITATIONS
SEARCH DETAIL
...